fashion -WSS

fashion

author：fashion 2025-09-07 06:46:50 - browse：15637

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Prosthetic arm enables patients to feel the objects they grip

WSS

David Sabatini, ex

Health insurers say they are turning to AI to cut costs, improve care

Latest bird flu infection made farmworker sicker than earlier cases

Setback for rare diseases as Taysha Gene Therapies pulls back

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Will an HIV vaccine ever be a reality?

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Report: NIH

What does generative AI mean for health care? We asked experts

CRISPR base editing slashes cholesterol levels in monkeys

Dobbs anniversary: the lost opportunity of abortion as health care

Study points to new risk in gene therapy death of Terry Horgan

At least 13 dead in Texas as scorching temps continue

CRISPR base editing slashes cholesterol levels in monkeys

In age of alternative facts, a scholarly course on calling out crap

The Karikó problem: Lessons for funding basic research

explore

Insmed lung disease drug hits target in key Phase 3 trial

IVG is promising — but it won’t replace IVF quite yet

Some top drug companies are starting to take action on climate

Startling documents reveal new facets of Sacklers' opioid empire

Scientists successfully use ultrasound imaging to map brain activity

Childbirth

hotspot

Wikipedia

hotspot

hotspot